-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
March 16, 2021, Hangzhou, China, and Ludwigshafen, Germany – BASF Venture Capital (BVC) has decided to invest in Hangzhou Bota Bio, an industrial synthetic biotechnology platform in Hangzhou, China.
and biology")
.
Industrial biotechnology (also known as "white biotechnology") uses living cells and enzymes to create feedstocks that allow products to be developed and manufactured more efficiently
.
Working together to bring sustainably produced ingredients to market
Working together to bring sustainably produced ingredients to marketEnho's interdisciplinary team of biologists, chemists, engineers and industry veterans has extensive experience in product development and commercialization and will continue to bring valuable and innovative products to the market
.
BASF itself is using fermentation and biocatalysis to produce products such as vitamins and enzymes, and is investigating processes for producing chemical building blocks from renewable feedstocks such as sugar and vegetable oils using white biotechnology
.
Markus Sobieda, Managing Director of BASF Ventures, said: "The founding members of Enhe Bio have extensive experience in biotechnology, chemistry and entrepreneurship
.
The investment will further expand Enhe Bio's product development and production capabilities
.